Experts say there are ways to reduce our risk of dementia, including diet and exercise, protecting against hearing loss, and maintaining social connections.

ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and ...

Groundbreaking research reveals potential link between cytomegalovirus (CMV) and Alzheimer's disease, offering new insights ...

This discovery is significant because there are currently no effective treatments for any type of dementia, including FTD.

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Share on PinterestThe virus causing cold sores may also be linked to Alzheimer’s risk, a new study suggests. Image credit: ...

Among the key findings, age at diagnosis emerged as the strongest predictor of survival time. For women diagnosed at age 60, ...

They have identified a vital cellular mechanism driving the most common cause of dementia. American researchers say the breakthrough marks a "promising" target for drug treatments that slow ...

CervoMed Inc.’s stock cratered early Tuesday after the biotech company said a midstage trial of a treatment for patients with dementia with Lewy bodies, or DLB, failed to meet its main goals.

These findings highlight a growing awareness and acceptance of cosmetic dermatologic treatments in pediatric care, particularly for conditions that can significantly impact a child’s quality of life.

In other words, sleeping pills may help some people get some shut-eye but using them as a preventative treatment to ward off Alzheimer's disease is still a hazy prospect that hangs on a now-shaky ...